• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hologic shares dip despite posting Q2 Beat

Hologic shares dip despite posting Q2 Beat

May 11, 2017 By Fink Densford

Hologic

Shares in Hologic (NSDQ:HOLX) fell today despite the medical device maker posting 2nd quarter earnings that beat expectations on Wall Street.

The Marlborough, Mass.-based company posted profits of $526.8 million, or $1.84 per share on sales of $715.4 million for the 3 months ended April 1, for bottom-line growth of 664% while sales grew 3.2% compared with the same period last year.

Adjusted to exclude 1-time items, earnings per share were 50¢, ahead of the 46¢ consensus on Wall Street, where analysts were looking for sales of $685.4 million

“Hologic posted good financial results in the second quarter, with both revenues and EPS exceeding our guidance. Our base business revenue grew 5.4% on a constant currency basis, led by our molecular diagnostics, surgical and international franchises. And at the same time, it was a transformational quarter from a strategic perspective, as we strengthened our portfolio of businesses for the long-term,” prez & CEO Steve MacMillan said in a prepared statement.

Hologic updated its guidance for the full fiscal 2017 year, raising expectations for revenue increase from between -1.7% and -0.3% to between 7.7% and 8.7%. Revenue is expected to be between $3 billion and $3.1 billion with earnings per share between $2.44 and $2.48.

“We are updating our 2017 financial guidance based on our good second-quarter results and the completion of our Cynosure acquisition. Underlying our forecast, we continue to expect solid, mid-single-digit growth in our ongoing, base business,” CFO Bob McMahon said in a press release.

Shares in Hologic have lowered 5.1% today, at $43.60 as of 3:52 p.m. EDT.

Filed Under: Business/Financial News, MassDevice Earnings Roundup Tagged With: Hologic

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy